289 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis C"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin
2 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 With Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
3 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
4 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 Coadministered With Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 (HIV-1) Coinfection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
5 Recruiting Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection
Conditions: Chronic Hepatitis C;   Genotype 4 Chronic Hepatitis C
Interventions: Drug: Simeprevir;   Drug: Sofosbuvir
6 Recruiting A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
Condition: Hepatitis C Virus
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: Ribavirin
7 Recruiting Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Condition: Hepatitis C Virus
Interventions: Drug: Simeprevir 150 mg;   Drug: Daclatasvir 60 mg;   Drug: Sofosbuvir 400 mg
8 Unknown  Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Conditions: HIV Infection;   Hepatitis C
Intervention: Behavioral: Contigent voucher incentive (CVI)
9 Recruiting A Study to Evaluate Chronic Hepatitis C Infection in Cirrhotic Adults With Genotype 1b Infection
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
10 Unknown  Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels
Condition: Chronic Hepatitis C
Intervention: Drug: Peg-Interferon alpha2a plus Ribavirin
11 Recruiting A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Condition: Chronic Hepatitis C Infection
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: ribavirin (RBV)
12 Recruiting A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With Sofosbuvir in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Dasabuvir;   Drug: Sofosbuvir;   Drug: Ribavirin
13 Unknown  Directly Observed Hepatitis C Treatment in Methadone Clinics
Conditions: Hepatitis C;   Medication Adherence
Interventions: Other: enhanced DOT (both pegylated interferon alfa-2a and ribavirin);   Other: standard DOT (PEG-DOT control arm)
14 Unknown  ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
15 Recruiting Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: TT-034
16 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   HCV
Interventions: Drug: ABT-493;   Drug: ABT-530
17 Unknown  Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Interferon Deficiency
Intervention: Drug: interferon alpha 2b
18 Unknown  Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition: Chronic Hepatitis C
Intervention: Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
19 Recruiting Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis;   Severe Renal Impairment;   End-stage Renal Disease
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: Ribavirin
20 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Sofosbuvir;   Drug: Ribavirin (RBV)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years